Nasdaq Most Active

Prism Marketview
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out

Home BioTech Page 2

Tag: BioTech

Healthcare professional in a white lab coat presenting medical information to an audience, illustrating clinical research and advances in dialysis access treatments.
October 12, 2026

Humacyte Sets Phase 3 Dialysis Access Presentation Ahead of Planned FDA Filing

Key Points Humacyte’s interim Phase 3 V012 results were accepted for a late-breaking oral presentation at ASN Kidney Week 2026. The randomized trial compares its…

Healthcare professional in blue scrubs assisting a young girl using crutches, illustrating pediatric mobility challenges and treatment needs associated with rare bone diseases.
October 12, 2026

AstraZeneca’s HPP Readout Puts Trial Design in Focus for Rare Bone Disease Stocks

AstraZeneca attributes its Phase 3 HICKORY miss in hypophosphatasia to trial design, as Mereo seeks a path forward with the FDA and Mirum wins approval…

World Mental Health Day awareness graphic featuring green lettering, a green mental health awareness ribbon, and a gray silhouette of a human head against a white background. The image highlights October 10 as World Mental Health Day.
October 09, 2026

Real Voices, Real Returns: 5 Mental Health Stocks Driving Change in 2026

World Mental Health Day 2026: Why Lived Experience Now Moves Markets This Saturday, October 10, marks World Mental Health Day. The World Federation for Mental…

Woman holding medication blister packs during a virtual consultation with a healthcare professional, illustrating telemedicine, acne treatment and dermatology care.
October 09, 2026

Sagimet Moves Ahead with U.S. Acne Trial as Denifanstat Shows Lasting Improvement

Key Points Sagimet is presenting long-term results for its experimental acne pill, denifanstat, at a dermatology conference in Las Vegas. A study in China reported…

Healthcare professional holding a blood sample labeled "Tumor Marker - Test" over a laboratory testing form, illustrating cancer biomarker testing and precision oncology diagnostics.
October 08, 2026

Myriad Genetics Advances Prostate Cancer Biomarker Through SOPHiA GENETICS Collaboration

Key Points Myriad Genetics is partnering with SOPHiA GENETICS to advance its prostate cancer-specific genomic instability score, or PrGIS, in precision oncology work involving AstraZeneca….

Stacks of gold coins, an upward-trending financial graph and a gold pie chart on a blue grid background, illustrating revenue growth and strong financial performance.
October 08, 2026

Profound Medical Expects Record Q3 2026 Revenue of $9.8 Million to $10 Million

Key Points Preliminary third-quarter 2026 revenue is expected to reach $9.8 million to $10.0 million, representing a quarterly record. Revenue is expected to rise approximately…

October 08, 2026

Rett Syndrome Awareness Month: Acadia Extends Drug Protection as Taysha Gene Therapy Nears Pivotal Data

Acadia has the first approved Rett syndrome treatment and a path to five more years of U.S. exclusivity. Taysha has finished dosing a pivotal trial…

Medical professional presenting brain scans to colleagues in a classroom, illustrating neurological research and advances in glioblastoma treatment.
October 08, 2026

BioLineRx and Hemispherian Bring GLIX1 Brain Cancer Research to SNO 2026

Key Points BioLineRx and Hemispherian will present two GLIX1 posters at the Society for Neuro-Oncology annual meeting in Philadelphia. Both presentations are scheduled for November…

Medical professional reviewing patient records beside an anatomical kidney model, illustrating medical research, kidney function and investigational cancer therapies.
October 08, 2026

Perspective Therapeutics Wins FDA Fast Track Status for Targeted Therapy in Rare Tumors

Key Points The FDA granted Fast Track designation to PSV359 for adults with FAP-positive solitary fibrous tumors that are locally advanced and unresectable and/or metastatic….

A red “Protected” stamp beside the word “Patent,” representing intellectual property protection and issued patents.
October 07, 2026

Armata Strengthens Phage Therapy Patents Ahead of Planned Phase 3 Trial

Key Points Armata announced two issued U.S. patents covering treatment methods involving its investigational bacteriophage candidates, AP-SA02 and AP-PA02. The AP-SA02 patent was issued October…

A tired mother holds her baby while sitting at a table with a laptop, illustrating the emotional and mental health challenges parents can face.
October 07, 2026

Owlet Partners With VillageFor to Expand Mental Health Support for Parents

Key Points Owlet launched a partnership with VillageFor to support new and expecting parents through pregnancy, postpartum and other paths to parenthood. Owlet360 members will…

Collage showing food safety testing, diagnostic equipment, cattle, agricultural technology, laboratory pipetting, crops and testing instruments representing Neogen’s food and animal safety businesses.
October 07, 2026

Neogen Raises FY27 Forecast as Growth Builds and Petrifilm Transfer Advances

Key Points Neogen’s fiscal first-quarter revenue rose 6.5% to $222.8 million, with core growth of 8.1%. Adjusted EBITDA increased 17% to $41.6 million, and adjusted…

Posts pagination

Previous page Page 1 Page 2 Page 3 … Page 33 Next page

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup

News

  • Latest
  • PRISM View
  • Biotech
  • Finance
  • Healthcare
  • Technology

Indexes

  • Aerospace & Defense
  • AI Datacenter and Infrastructure
  • Biotech
  • Cannabis
  • Comms and Media
  • Consumer Products
  • Crypto Mining
  • Cybersecurity
  • EV
  • Fintech
  • Global Health
  • Healthcare
  • MedDevices
  • Mental Health
  • New Energy
  • NextGen Tech & AI
  • Oil & Gas
  • Pet Care
  • Pharmaceuticals
  • Psychedelics
  • Semiconductors
  • Space
  • Sports
  • Weight Loss
  • Wellness
  • Women’s Health
  • Home
  • About Us
  • Contact Us

Copyright © 2026 PRISM MarketView. All rights reserved.

  • Terms & Conditions
  • Privacy Policy
  • Disclaimer